Log in


Advancing translational life sciences research and academic technology transfer

  • Home
  • Spotlight on Wistar COVID-19 Researcher: Paul Lieberman, Ph.D., The Wistar Institute

Spotlight on Wistar COVID-19 Researcher: Paul Lieberman, Ph.D., The Wistar Institute

3 Aug 2020 8:47 AM | Anonymous

Creating a new drug from scratch takes many years and billions of dollars. While discovery of new molecules against SARS-CoV-2 and other emerging viruses is imperative, the world also needs solutions for COVID-19 now. This is why there has been wide interest in repurposing existing drugs, for which safety and pharmacologic profiles are already available, as a viable strategy to save critical time and resources and quickly discover potential candidate drugs to combat the pandemic.

<<FULL STORY>>

Contact Us

admin@biostrategypartners.org
717-514-0436

P.O. Box 83 Boiling Springs, PA 17007



Copyright 2017, BioStrategy Partners. All rights reserved.   
Powered by Wild Apricot Membership Software